
PolyNovo
PNV.AXPolyNovo Limited Price (PNV.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
700,382,751
(2.3272)%Description
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $1.125-2.78
- Market Cap 870.46M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Devices
- ceo: Mr. Swami Raote BPHARM, M.B.A.
- IPO Date: November, 30, 1998
- Country: AU
- Currency: AUD
- Headquaters: Port Melbourne, VIC
- Employees: 282
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
